Efficacy of Glimepiride for the Treatment of Diabetes Occurring During Glucocorticoid Therapy
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
lacenta growth factor (PlGF) is a close homolog of vascular endothelial growth factor (VEGF), shares receptors with VEGF, and stimulates angiogenesis (1).Intravitreous PlGF levels are elevated in proliferative diabetic retinopathy (PDR) (2), but the relationship between PlGF levels and VEGF levels or clinical activity remains unclear.We attempted to ascertain whether intravitreous PlGF levels correlate with VEGF levels or clinical activity in PDR.We assayed PlGF and VEGF levels in vitreous samples from 50 consecutive patients with PDR (31 patients) and macular hole (nondiabetic control subjects, 19 patients) who underwent pars plana vitrectomy.The PDR stage was classified as active (16 patients) if there were new preretinal capillaries and as quiescent (15 patients) if the vasoproliferation consisted of only large vessels (3, 4).Informed consent was obtained from each patient.The undiluted vitreous samples were collected during the vitrectomy before intraocular infusion.Vitreous PlGF and VEGF concentrations were measured using an enzyme-linked immunosorbent assay (ELISA) for PlGF and VEGF (R&D Systems, Minneapolis, MN) according to the manufacturer's protocol.The total protein concentration of the vitreous humor was measured using a BCA protein assay kit (Pierce Chemical, Rockford, IL).The Mann-Whitney U test was used to compare vitreous concentrations of PlGF and VEGF.Spearman's rank correlation test was used to examine correlations.PlGF and VEGF levels (median range) in PDR (PlGF, 100.6 pg/ml, range 7.6 -1,038.6;VEGF 653.9 pg/ml, 9.0 -5,423.8)were significantly higher (P Ͼ 0.0001) than in the control (PlGF 7.0 pg/ ml, 7.0 -12.1;VEGF 9.0 pg/ml, 9.0 -10.0).Moreover, the differences remained highly significant (P Ͻ 0.0001) when the ratio of PlGF and VEGF to protein was considered (PlGF 14.6, 1.5-250.7 vs. 2.6, 1.1-4.1;VEGF 95.5, 2.0 -904.0 vs. 3.0, 1.4 -5.3) (4,5).The ratio of PlGF and VEGF to protein in active PDR patients was significantly higher than that in quiescent PDR patients (PlGF 33.5, 2.7-250.7 vs. 11.1, 1.5-35.8,P ϭ 0.0039; VEGF 130.1, 7.8 -904.0 vs. 73.9,2.0 -150.3,P ϭ 0.0328).Intravitreous PlGF levels significantly correlated with intravitreous VEGF levels in both PDR patients (r ϭ 0.824, P Ͻ 0.0001) and total subjects (r ϭ 0.857, P Ͻ 0.0001).Neovascularization is the most important event in PDR.PlGF stimulates angiogenesis in vivo (1).PlGF is detected in the fibrovascular membranes of PDR (2), and PlGF mRNA expression significantly increases in retina during diabetic retinopathy (6).In this study, intravitreous PlGF levels were significantly higher in active PDR than in quiescent PDR, suggesting that PlGF is involved in the developing stages of PDR.PlGF does not directly induce endothelial cell proliferation or vascular permeability but acts indirectly by potentiating the activity of VEGF (7,8).Genetic studies indicate a synergism between PlGF and VEGF in pathological angiogenesis (9).In the present study, intravitreous PlGF levels significantly correlated with VEGF levels.Taken together, these results suggest that PlGF might have a cooperative role with VEGF in the progression of PDR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alford, F., Beck-Nielsen, H., Ward, G. M., & Henriksen, J. E. (1997) · Diabetologia · doi:10.1007/s001250050847 · Cited by 115
Cited by
Tamez-Pérez, H. E. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i8.1073 · Cited by 387
Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions
Li, J.-X., & Cummins, C. L. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00683-6 · Cited by 257
Steroid-induced hyperglycemia: An underdiagnosed problem or clinical inertia? A narrative review
Bonaventura, A., & Montecucco, F. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.006 · Cited by 108
Use of Empagliflozin in Recipients of Kidney Transplant: A Report of 8 Cases
Attallah, N., & Yassine, L. (2019) · Transplantation Proceedings · doi:10.1016/j.transproceed.2019.05.023 · Cited by 62
Glucocorticoid-Induced Hyperglycemia: A Neglected Problem
Cho, J.-H., & Suh, S. (2024) · Endocrinology and Metabolism · doi:10.3803/enm.2024.1951 · Cited by 63
Metadata
- Authors
- Kasayama, S., Tanaka, T., Hashimoto, K., Koga, M., & Kawase, I.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2002-12-01
- Volume
- 25
- Issue
- 12
- Pages
- 2359-2360
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2059596187
- Cited by
- 28
- References
- 1
- FWCI
- 0.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of Glimepiride for the Treatment of Diabetes Occurring During Glucocorticoid Therapy. https://app.cochat.ai/papers/10.2337/diacare.25.12.2359
- The paper
- Kasayama, S., Tanaka, T., Hashimoto, K., Koga, M., & Kawase, I. (2002). Efficacy of Glimepiride for the Treatment of Diabetes Occurring During Glucocorticoid Therapy. Diabetes Care. https://doi.org/10.2337/diacare.25.12.2359
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.